Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease
- PMID: 23411394
- DOI: 10.1016/j.jalz.2012.12.004
Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease
Abstract
Current research including the basic biology of Alzheimer's disease (AD) provides a foundation to explore whether our current state of knowledge is sufficient to initiate prevention studies and allow us to believe prevention of AD is possible. Current research and recently revised criteria for the diagnosis of AD by the National Institutes on Aging and the Alzheimer's Association suggest a continuum of disease from preclinical asymptomatic to symptomatic Alzheimer's dementia. In light of these revised criteria, the possibility of secondary prevention and even primary prevention is under discussion. The Alzheimer's Association Research Roundtable convened a meeting to discuss the rationale and feasibility of conducting secondary prevention trials in AD.
Copyright © 2013 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Assessing cognition and function in Alzheimer's disease clinical trials: do we have the right tools?Alzheimers Dement. 2014 Nov;10(6):853-60. doi: 10.1016/j.jalz.2014.07.158. Epub 2014 Nov 15. Alzheimers Dement. 2014. PMID: 25458309 Review.
-
The epidemiology of Alzheimer's disease: laying the foundation for drug design, conduct, and analysis of clinical trials.Alzheimers Dement. 2012 May;8(3):237-42. doi: 10.1016/j.jalz.2011.12.005. Alzheimers Dement. 2012. PMID: 22546356
-
Revisiting the framework of the National Institute on Aging-Alzheimer's Association diagnostic criteria.Alzheimers Dement. 2013 Sep;9(5):594-601. doi: 10.1016/j.jalz.2013.05.1762. Alzheimers Dement. 2013. PMID: 24007744
-
Prevention trials in Alzheimer's disease: an EU-US task force report.Prog Neurobiol. 2011 Dec;95(4):594-600. doi: 10.1016/j.pneurobio.2011.08.014. Epub 2011 Sep 10. Prog Neurobiol. 2011. PMID: 21925234
-
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease.Alzheimers Dement. 2009 Mar;5(2):133-6. doi: 10.1016/j.jalz.2009.01.006. Alzheimers Dement. 2009. PMID: 19328443
Cited by
-
Primary and Secondary Prevention Trials in Alzheimer Disease: Looking Back, Moving Forward.Curr Alzheimer Res. 2017;14(4):426-440. doi: 10.2174/1567205013666160930112125. Curr Alzheimer Res. 2017. PMID: 27697063 Free PMC article. Review.
-
The earlier the better: Alzheimer's prevention, early detection, and the quest for pharmacological interventions.Cult Med Psychiatry. 2014 Jun;38(2):217-36. doi: 10.1007/s11013-014-9370-2. Cult Med Psychiatry. 2014. PMID: 24668497
-
Immunotherapy for Alzheimer's disease: past, present and future.Front Aging Neurosci. 2014 Jun 10;6:114. doi: 10.3389/fnagi.2014.00114. eCollection 2014. Front Aging Neurosci. 2014. PMID: 24959143 Free PMC article. Review.
-
Expanding engagement with the ethical implications of changing definitions of Alzheimer's disease.Lancet Psychiatry. 2017 Apr;4(4):e6-e7. doi: 10.1016/S2215-0366(17)30089-5. Lancet Psychiatry. 2017. PMID: 28347435 Free PMC article. No abstract available.
-
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.Alzheimers Dement. 2016 Mar;12(3):292-323. doi: 10.1016/j.jalz.2016.02.002. Alzheimers Dement. 2016. PMID: 27012484 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
